Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
However, these animal findings are concerning enough that drug manufacturers and regulatory agencies have recommended caution until we have better human data
Stability of reconstituted research materials
If Foundayo's clinical outcomes hold up in real-world use (the Phase 3 ATTAIN-1 trial showed 11.2% mean weight loss at 72 weeks on the 36 mg dose, or 12.4% among participants who stayed on treatment), it could become the go-to affordable GLP-1 option and put downward pressure on Wegovy and Zepbound pricing
The RDA for pregnant women is 2.6 mcg per day, and for breastfeeding women, it is 2.8 mcg per day
US$ 29.82
US$ 26.43
US$ 24.10
US$ 24.75
